Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients.

Nir HirshorenRoni YoeliJonathan E CohenJeffrey M WeinbergerNadia KaplanSharon MerimsTamar PeretzMichal Lotem

Published in: PloS one (2020)

Response rate to CPI is significantly improved in patients with melanoma of the head and neck and they have a trend towards improved, long standing, overall survival.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
dna damage
prognostic factors
cell cycle
oxidative stress
cell proliferation
patient reported